716 results on '"Coleman, Michel P."'
Search Results
2. Trends in short-term survival from distant-stage cutaneous melanoma in the United States, 2001-2013 (CONCORD-3)
3. European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
4. Overview of Main Mechanisms Involved in Social Disparities in Cancer Incidence and Prognosis
5. Social Disparities in Survival from Breast Cancer in Europe
6. Disparities in Cancer Survival in Adults in Europe: The CONCORD Programme
7. Social Inequities in Cancer: Why Develop Scientific Research?
8. World-wide trends in net survival from pancreatic cancer by morphological sub-type: An analysis of 1,258,329 adults diagnosed in 58 countries during 2000–2014 (CONCORD-3)
9. Survival from five common cancers in Georgia, 2015–2019 (CONCORD)
10. How should implementation of the human right to health be assessed? A scoping review of the public health literature from 2000 to 2021
11. The Right to Health in Times of Pandemic : What Can We Learn from the UK’s Response to the COVID-19 Outbreak?
12. Ethnic, racial and socioeconomic disparities in breast cancer survival in two Brazilian capitals between 1996 and 2012
13. The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study
14. Sustainable care for children with cancer: a Lancet Oncology Commission
15. Pancreatic cancer incidence and survival and the role of specialist centres in resection rates in England, 2000 to 2014: A population-based study
16. Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988-2011: a population-based study.
17. Predictors of Early Death and Survival Among Children, Adolescents and Young Adults with Acute Myeloid Leukemia in California, 1988-2011: A Population-Based Study
18. Are socio-economic inequalities in breast cancer survival explained by peri-diagnostic factors?
19. The CONCORD–Lancet Global Commission on Cancer
20. Which indicators of early cancer diagnosis from population-based data sources are associated with short-term mortality and survival?
21. The CONCORD–LancetGlobal Commission on Cancer
22. Excess mortality among essential workers in England and Wales during the COVID-19 pandemic: an updated analysis
23. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries
24. The global burden of women’s cancers: a grand challenge in global health
25. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)
26. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)
27. The people behind the numbers: women with breast cancer
28. The effect of multiple primary rules on cancer incidence rates and trends
29. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3)
30. Worldwide trends in esophageal cancer survival, by sub‐site, morphology, and sex: an analysis of 696,974 adults diagnosed in 60 countries during 2000‐2014 (CONCORD‐3).
31. The impact of age at diagnosis on socioeconomic inequalities in adult cancer survival in England
32. How many cancer deaths could New Zealand avoid if five‐year relative survival ratios were the same as in Australia?
33. 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study
34. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
35. Cervical cancer in Saudi Arabia: trends in survival by stage at diagnosis and geographic region
36. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)
37. National surveillance of cancer survival in Iran ( IRANCANSURV ): Analysis of data of 15 cancer sites from nine population‐based cancer registries
38. Control of data quality for population-based cancer survival analysis
39. Cancer survival: global surveillance will stimulate health policy and improve equity
40. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study
41. Impact of national cancer policies on cancer survival trends and socioeconomic inequalities in England, 1996-2013: population based study
42. Reply to comments by Dr. Frisch and Dr. Van Howe
43. Colon cancer survival in the United States by race and stage (2001‐2009): Findings from the CONCORD‐2 study
44. Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: Findings from the CONCORD‐2 study
45. Population‐based cancer survival in the United States: Data, quality control, and statistical methods
46. Rectal cancer survival in the United States by race and stage, 2001 to 2009: Findings from the CONCORD‐2 study
47. Population‐based cancer survival (2001 to 2009) in the United States: Findings from the CONCORD‐2 study
48. Public health surveillance of cancer survival in the United States and worldwide: The contribution of the CONCORD programme
49. Long-term trends in incidence, survival and mortality of primary penile cancer in England
50. Characteristics of patients with missing information on stage: a population-based study of patients diagnosed with colon, lung or breast cancer in England in 2013
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.